New lung cell type discovered

August 2, 2018 by Kevin Jiang, Harvard Medical School
Pulmonary ionocytes (orange) extend through neighboring epithelial cells in the upper respiratory tract of the mouse, to the surface of the epithelial lining. Cell nuclei in cyan. Credit: Montoro et al./Nature 2018

In separate studies published online in Nature on Aug. 1, two independent research teams report the discovery of a new, rare type of cell in the human airway. These cells appear to be the primary source of activity of the CFTR gene, mutations to which cause cystic fibrosis, a multiorgan disease that affects more than 70,000 people worldwide.

Despite decades of study on CFTR and progress in treating the disease, there is still no cure. The new findings show that CFTR activity is concentrated in a small, previously unknown population of cells, which serve as promising targets for future therapeutic strategies against .

The researchers named the cells "pulmonary ionocytes" due to similarities with ionocytes, a type of cell found in the gills of freshwater fish and frog skin, which regulate salt balance.

One group was led by scientists from Harvard Medical School (HMS) and the Novartis Institutes for Biomedical Research (NIBR). The other group was led by HMS researchers based at Massachusetts General Hospital and scientists at the Broad Institute of MIT and Harvard.

"As researchers work toward cures for cystic fibrosis, knowing you are looking at 1 percent of the cell population seems essential for any type of trouble shooting to improve a therapy or develop new therapies," said Allon Klein, co-corresponding author of one of the Nature studies and assistant professor of systems biology at HMS.

The studies also revealed the characteristics of other new, rare and poorly understood cell types, which expands the current understanding of lung biology and disease.

"Cystic fibrosis is an amazingly well-studied disease, and we're still discovering completely new biology that may alter the way we approach it," said Jayaraj Rajagopal, co-corresponding author of the second study and HMS professor of medicine at Mass General. "We have the framework now for a new cellular narrative of lung disease."

Single-cell surprise

Both teams set out to build an atlas of the cells that make up the airway. Using single-cell sequencing technology, they analyzed gene expression in tens of thousands of individual cells isolated from human and mouse airways—one cell at a time.

New lung cell type discovered
A live-imaging technique captures cilia beating and the transport of debris across the surface of the epithelium. Pulmonary ionocytes appear to play a role in this process, which is necessary for clearing mucus from the airways. Video: Daniel Montoro, Hui Min Leung, Vladimir Vinarsky.

Comparing patterns of gene expression and using previously described cells as references, the teams created comprehensive catalogues of different cell types and states, as well as their abundance and distribution.

The teams' analyses mapped out the genetic identities of both known and previously undescribed cell types. One new cell type, which they named pulmonary ionocytes, was particularly striking as these cells expressed higher levels of CFTR than any other cell.

Pulmonary ionocytes appear to play a role in this process, which is necessary for clearing mucus from the airways. Video: Daniel Montoro, Hui Min Leung, Vladimir Vinarsky.

Identified in the late 1980s, CFTR (cystic fibrosis transmembrane conductance regulator) codes for a protein that transports chloride ions across cell membranes. Mutations to CFTR can lead to the buildup of thick mucus in the lung, pancreas and other organs, which in turn leads to frequent respiratory infections and other symptoms that characterize cystic fibrosis. Scientists have long assumed that CFTR is expressed at low levels in ciliated cells, a common airway cell type.

The new studies, however, suggest that the majority of CFTR expression occurs in pulmonary ionocytes, which make up only around 1 percent of airway cells. Klein, along with Aron Jaffe, a co-leader of respiratory disease research at NIBR, and colleagues additionally showed that the activity of CFTR, not just its expression, relates to the number of pulmonary ionocytes in the tissue.

"With single-cell sequencing technology, and dedicated efforts to map cell types in different tissues, we're making new discoveries—new cells that we didn't know existed, cell subtypes that are rare or haven't been noticed before, even in systems that have been studied for decades," said Broad core institute member and MIT professor of biology Aviv Regev, co-corresponding author of the study with Rajagopal.

When Regev, Rajagopal and colleagues disrupted a critical molecular process in pulmonary ionocytes in mice, they observed the onset of key features associated with cystic fibrosis, notably the formation of dense mucus. This finding underscores how important these cells are to airway-surface regulation, the researchers said.

Together, the teams' discoveries point to new strategies for treating cystic fibrosis, such as increasing the amount of pulmonary ionocytes to increase the amount of CFTR activity, said Jaffe, who is co-corresponding author of the study with Klein.

The identification of these cells can also help guide teams trying to use gene therapy to correct CFTR mutations, the authors suggest.

Pulmonary ionocytes (green) dot the landscape of ciliated cells (magenta) of the mouse lung airway lining. Credit: Montoro et al./Nature 2018
"We can use this information to be a bit more clever when we devise therapeutic approaches to cystic fibrosis," Jaffe said.

Here and rare

The teams' analyses also shed light on new, rare or poorly described cell states and subtypes, and characterized changes to certain cells after injury or during development.

Klein, Jaffe and colleagues, for example, identified cell states that emerge or expand following damage or injury by studying regenerating tracheas. Using InDrops, a single-cell sequencing technology developed at HMS by Klein and colleagues, at multiple points during regeneration, the team could track how cell states specific to the injury response transitioned over time.

Rajagopal, Regev and colleagues developed a new method called Pulse-Seq to monitor development of cell types from their progenitors in the mouse airway, which were verified in human tissue. By adding a label to progenitor cells, they showed that mature cells in the airway arise from a common progenitor known as basal cells.

A comprehensive atlas of cell types and their genetic fingerprints, both in normal conditions and in development and regeneration, serves as potential baseline data for future studies of diseases and other health-related conditions, according to the research teams.

Rajagopal, Regev and colleagues, for example, found that a gene linked to asthma development is specifically expressed by ciliated cells. Another gene linked with asthma is expressed in tuft cells, which separated into at least two groups—one that senses chemicals in the airway and another that produces inflammation. These findings may inform understanding and treatment of the disease.

"We've uncovered a whole distribution of that seem to be functionally relevant," Rajagopal said. "What's more, genes associated with complex lung diseases can now be linked to specific that we've characterized. The data are starting to change the way we think about lung diseases such as cystic fibrosis and asthma."

Explore further: Researchers discover new type of lung cell, critical insights for cystic fibrosis

More information: Lindsey W. Plasschaert et al, A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte, Nature (2018). DOI: 10.1038/s41586-018-0394-6

Daniel T. Montoro et al, A revised airway epithelial hierarchy includes CFTR-expressing ionocytes, Nature (2018). DOI: 10.1038/s41586-018-0393-7

Related Stories

Researchers discover new type of lung cell, critical insights for cystic fibrosis

August 1, 2018
Researchers have identified a rare cell type in airway tissue, previously uncharacterized in the scientific literature, that appears to play a key role in the biology of cystic fibrosis. Using new technologies that enable ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Cystic fibrosis study offers new understanding of silent changes in genes

May 17, 2017
Researchers studying the root cause of cystic fibrosis have made a major advance in our understanding of silent gene changes with implications for the complexity of cystic fibrosis. The findings are published today in [16 ...

Lipid-based nanoparticles enable improved therapy for cystic fibrosis patients

June 25, 2018
Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients.

Improved airway-targeted gene delivery in a pig model of cystic fibrosis

September 8, 2016
Cystic fibrosis (CF) is characterized by accumulation of thick mucus in the lungs and is associated with a high incidence of bacterial infection. Mutations in the gene encoding CF transmembrane conductance regulator (CFTR) ...

An 'unconventional' path to correcting cystic fibrosis

September 1, 2011
Researchers have identified an unconventional path that may correct the defect underlying cystic fibrosis, according to a report in the September 2nd issue of the journal Cell. This new treatment dramatically extends the ...

Recommended for you

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

Researchers explore new way of killing malaria in the liver

December 8, 2018
In the ongoing hunt for more effective weapons against malaria, international researchers said Thursday they are exploring a pathway that has until now been little studied—killing parasites in the liver, before the illness ...

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.